ADR News Bulletin 2020 December (Volume 22 Number 3)

Bulletin Highlights:

  • Advisory on restriction on the use of montelukast and neuropsychiatric effects
  • Characteristics of sibutramine-induced adverse events due to adulterated health products
  • Reminder to verify HLA-B*1502 status in new patients of Asian ancestry before starting carbamazepine treatment
  • Voluntary withdrawal of Esmya™ (ulipristal acetate) Tablet 5mg in Singapore due to risk of serious liver injury
  • Risk of drug-induced liver injury associated with the use of pirfenidone
  • AE Case in Focus: Test Yourself
  • Reporting vaccine adverse events

 

Click on the link below to download the issue in PDF:

ADR_News_Dec2020_Vol22_No32312 KB

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

15 Dec 2020
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.